Feature | Cristen C. Bolan
Researchers are using speckle tracking imaging in heart ultrasound to monitor the health of transplant acceptance, and ...
June 09, 2008 
News
June 10, 2008 - At the Digestive Disease Week Conference, Cook Medical announced that it has been granted 510(k) clearance from the FDA for use of the Evolution Controlled Release Esophageal Stent System, a stent designed to improve the quality of life for patients with esophageal cancer.
June 09, 2008 News
June 10, 2008 – MEDSEEK, a provider of enterprise portal management solutions, said today it is supporting Microsoft ...
June 09, 2008 Sponsored Content
Sponsored Content
Videos | Radiology Business
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
November 11, 2025 News
June 10, 2008 – Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current ...
June 09, 2008 
Feature | Amy Ballard, M.Ed., director of research, Arkansas Urology
Could the treatment of Alzheimer’s disease one day become as routine as treating high cholesterol?
June 09, 2008 News
June 10, 2008 - Press Ganey Associates Inc. today released “The 2008 Emergency Department Pulse Report: Patient ...
June 09, 2008 Sponsored Content
Feature | Breast Imaging
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
October 24, 2025 News
June 10, 2008 – A new calcium scoring method, which takes into account not only the amount of calcified plaque build-up ...
June 09, 2008 News
June 10, 2008 - Wright Medical Group Inc., an orthopedic medical device company, said it has acquired certain assets of ...
June 09, 2008 Technology
Cook Medical's FDA-cleared Evolution Controlled Release Esophageal Stent System is a stent designed to improve the quality of life for patients with esophageal cancer.
June 09, 2008 Sponsored Content
Sponsored Content
Videos | Radiology Business
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
October 09, 2025 News
June 9, 2008 - Siemens unveiled the ACUSON SC2000 volume imaging ultrasound system, which acquires nonstitched, real ...
June 08, 2008 News
June 9, 2008 - Curlin Medical was recently awarded a three-year contract to provide its advanced pain management-local ...
June 08, 2008 
Technology
Candelis received 510(k) marketing clearance for its ImageGrid Mammography Web Viewer and ImageGrid Radiology Web Viewer ...
June 08, 2008 Sponsored Content
Case Study | PACS
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
February 03, 2025 Technology
Acusphere has submitted a New Drug Application (NDA) to the FDA for approval to market Imagify (Perflubutane Polymer Microspheres for Injectable Suspension), an ultrasound imaging agent for the detection of coronary artery disease, which could prove as accurate as nuclear stress testing.
June 08, 2008 News
June 9, 2008 – Electronic health records maker MediNotes Corp. said it added 199 new software agreements with new and ...
June 08, 2008 
Technology
Toshiba Teli America introduced the T24MSA001-MD medical-grade 24-inch LCD color widescreen monitor with full HD (1,080 ...
June 08, 2008 Technology
ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.
June 08, 2008 
Feature | Nadim Daher, industry analyst, Medical I
The future is looking bright for virtual colonoscopy (CTC) after encouraging news came out that the Centers for Medicare ...
June 08, 2008 News
June 9, 2008 - At the request of its membership, the American College of Physicians (ACP) recently conducted an ...
June 08, 2008 Technology
The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s tentatively approved product is a generic of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.
June 08, 2008 News
June 9, 2008 - Siemens Medical Solutions gained FDA 510(k) market clearance for the SOMATOM Definition AS, what is said ...
June 08, 2008 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now